Impact of dysexecutive syndrome in quality of life in Alzheimer disease: What we know now and where we are headed

Ribas M.Z.; Paticcie G.F.; Noleto F.M.; Ramanzini L.G.; Veras A.D.O.; Dall'Oglio R.; Filho L.B.D.A.; Martins da Silva J.G.; Lima M.P.P.; Teixeira B.E.; Nunes de Sousa G.; Alves A.F.C.; Vieira Lima L.M.F.; Sallem C.C.; Garcia T.F.M.; Ponte de Oliveira I.M.; Rocha R.S.D.C.; Juca M.D.S.; Barroso S.T.; Claudino dos Santos J.C.

Impact of dysexecutive syndrome in quality of life in Alzheimer disease: What we know now and where we are headed

Tipo

Artigo de revisão

Data de publicação

2023

Periódico

Ageing Research Reviews

Citações (Scopus)

3

Autores

Ribas M.Z.
Paticcie G.F.
Noleto F.M.
Ramanzini L.G.
Veras A.D.O.
Dall'Oglio R.
Filho L.B.D.A.
Martins da Silva J.G.
Lima M.P.P.
Teixeira B.E.
Nunes de Sousa G.
Alves A.F.C.
Vieira Lima L.M.F.
Sallem C.C.
Garcia T.F.M.
Ponte de Oliveira I.M.
Rocha R.S.D.C.
Juca M.D.S.
Barroso S.T.
Claudino dos Santos J.C.

Resumo

© 2023 Elsevier B.V.Alzheimer's disease (AD) is a common form of dementia that leads to multiple repercussions in the patient's life. This condition's clinical characteristics include loss of memory, temporal and spatial disorientation, language or executive dysfunction, and subsequent decline of social function. Dysexecutive syndrome (DS), the second most frequent neuropsychological dysfunction in AD, affects multiple brain areas and causes cognitive, behavioral, and emotional difficulties. We aimed to analyze the association between DS and AD and elucidate possible lack of evidence that may urge further research on this theme. Especially when dealing with such a disabling disease, where new findings can directly imply a better prognosis.

Assuntos Scopus

Alzheimer Disease , Brain , Cognitive Dysfunction , Humans , Neuropsychological Tests , Quality of Life